Professor Ellis talks to ecancertv about the upcoming Targeted Anticancer Therapies Congress (TAT 2015). He attests to the importance of the congress in aiding the intellectual development of oncologists, doctors and industry. This is especially true in the case of emerging new therapies where TAT provides a unique forum for information – both positive and negative – to be freely exchanged, cutting across different fields of basic and clinical research.